CLINICAL CHARACTERISTICS AND OUTCOMES FOR BENIGN AND MALIGNANT SOLITARY FIBROUS TUMOR / HEMANGIOPERICYTOMA (SFT/HPC) – A SINGLE CENTER EXPERIENCE.
Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.
CLINICAL CHARACTERISTICS AND OUTCOMES FOR BENIGN AND MALIGNANT SOLITARY FIBROUS TUMOR / HEMANGIOPERICYTOMA (SFT/HPC) – A SINGLE CENTER EXPERIENCE
Nicholas DeVito, M.D.; Evita Henderson, M.D.; Gang Han, Ph.D.; Damon Reed, M.D.; Marilyn Bui, M.D., Ph.D.; Robert Lavey, M.D., M.P.H.; Lary Robinson, M.D.; Jonathan S. Zager, M.D.; Ricardo J Gonzalez, M.D.; Vernon K. Sondak, M.D.; G. Douglas Letson, M.D.; Anthony Conley, M.D.
Moffitt Cancer Center, University of South Florida, Tampa, FL, USA
By univariate analysis, benign vs. malignant variant
positively impacted overall survival (P=0.02)
By univariate analysis, complete resection positively
impacted overall survival (P<0.0001, HR 0.09)